Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague

Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however, USAMRIID has developed a recombinant fusion protein, F1-V, that has been shown to induce protection against pneum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Biomater
Main Authors: Wagner, Danielle A, Kelly, Sean M, Petersen, Andrew C, Peroutka-Bigus, Nathan, Darling, Ross J, Bellaire, Bryan H, Wannemuehler, Michael J, Narasimhan, Balaji
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012387/
https://ncbi.nlm.nih.gov/pubmed/31610342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2019.10.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados